Patent brokers without upfront fees work on contingency — a percentage of the sale price, nothing in advance.
That aligns their incentive with yours. They are paid only if you are.
It also means they select hard. Unpaid effort on an asset that does not sell is a loss, so most patents offered get declined.
Which makes "will you take this on" the first real valuation you receive, and it is free.
The models
| Model | You pay | Broker's incentive |
|---|---|---|
| Contingency / success fee | Nothing upfront, % of sale | Aligned — paid on sale only |
| Retainer plus success fee | Fee plus % | Partly aligned |
| Fee-for-service | Fixed fees | Paid regardless of outcome |
| Invention promotion | Upfront fees | Paid by you, not by a buyer |
The last row is a different business. A broker sells patents to buyers; a promotion service sells services to inventors.
Mixed models are legitimate. A retainer covering marketing materials with a reduced commission is a real structure, provided it is stated plainly.
What "no upfront fee" may still exclude
| Item | Often billed separately |
|---|---|
| Valuation report | Sometimes |
| Marketing materials | Sometimes |
| Claim charts or evidence of use | Frequently |
| Prosecution or continuation work | Yes |
| Legal documentation | Usually |
| Maintenance fees during the process | Always yours |
| Foreign annuities | Yours |
Maintenance fees stay with you throughout. A sale process running across a fee deadline means paying it, and a lapsed patent mid-process is worth nothing.
| Fee | Due after grant | Large | Small | Micro |
|---|---|---|---|---|
| First | 3.5 years | $2,150 | $860 | $430 |
| Second | 7.5 years | $4,040 | $1,616 | $808 |
| Third | 11.5 years | $8,280 | $3,312 | $1,656 |
| Total | $14,470 | $5,788 | $2,894 |
Why patents get declined
| Reason | Detail |
|---|---|
| Nobody practises the claims | The largest single reason |
| Short remaining term | Under 3 years is very difficult |
| Ownership chain gaps | Blocking, not discounting |
| Narrow claims easily designed around | No buyer motivation |
| Not in force | 58.6% of US utility patents are abandoned |
| No documented evidence of use | Speculative |
| Single patent, no family | Less leverage |
| Ipiry Patent Survival Curve v1.0 | Rate |
|---|---|
| Survive the 3.5-year fee (2022 cohort) | 85.8% |
| Survive the 7.5-year fee (2018 cohort) | 64.6% |
| Reach full term (2014 cohort) | 41.4% |
| Abandoned before full term | 58.6% |
Computed from 27,273,654 USPTO maintenance fee records covering 8,262,336 US utility patents — see the patent survival curve.
A decline is information. It usually means the asset would not clear diligence, and finding that out for free is worth having.
Questions before signing
| Ask | Weak answer |
|---|---|
| What does the commission cover? | Vague |
| What is billed separately? | "It depends" |
| Have you completed comparable sales? | No examples |
| How long is the exclusivity period? | Open-ended |
| What if I find a buyer myself? | Commission on everything, forever |
| Who are your typical buyers? | Cannot say |
| How is my confidential information handled? | No NDA offered |
| Do you cover the foreign family? | Unclear |
| What happens if it does not sell? | No exit |
Open-ended exclusivity is the term to fix. A defined period with a clear end lets you try another route if nothing happens.
Carve-outs for buyers you introduce are negotiable and worth raising.
Distinguishing a promotion service
Federal law requires invention promoters to disclose under 35 U.S.C. §297, in writing, before you contract:
- Total customers in the past five years
- How many received a net financial profit
- How many received licence agreements
- Any other trading names
| Red flag | Meaning |
|---|---|
| They contacted you first | Enthusiasm preceded evaluation |
| A paid evaluation returns positive | Positive evaluations are the product |
| Will not give the §297 numbers | The numbers are bad |
| Pressure to decide quickly | Filing deadlines are real; sales deadlines are not |
| Large upfront fee | Submission is cheap; the fee is the business |
| No named registered attorney or agent | Nobody accountable |
Read the net-profit figure, not the customer count. See submit invention ideas for royalties.
Preparing before you approach anyone
| Step | Why | Cost |
|---|---|---|
| 1. Verify in force in Patent Center | Dead patents do not sell | Free |
| 2. Check the recorded chain | Gaps stop transactions | Free |
| 3. Confirm no unreleased security interest | Same | Free |
| 4. Calculate remaining term correctly | Continuations run from the parent | Free |
| 5. Search for products practising the claims | The value driver | Free to screen |
| 6. Draft a claim chart on the best candidate | Evidence | Time |
| 7. Gather file histories and family details | Diligence pack | Free |
Step five is what changes the answer. A documented chart against a shipping product is the largest single factor in what a buyer pays. See patent infringement search.
Steps one to five are free and they are the same checks a broker will run.
Worked example: two approaches
Two owners with similar patents, both approaching contingency brokers.
| Owner A | Owner B | |
|---|---|---|
| In-force verified | No | Yes |
| Chain of title checked | No | Yes — gap found and fixed |
| Remaining term | 4 years, miscalculated as 11 | 9 years, verified |
| Evidence of use | None | Chart against 2 shipping products |
| Family | US only | US + EP + CN |
| Timing | 6 weeks before a fee deadline | 14 months before |
| Outcome | Declined by three brokers | Engaged, sold |
Owner A's term miscalculation was the continuation trap — the patent was filed as a continuation of a much earlier parent, so it expired seven years sooner than the filing date suggested.
Owner B's chain gap was found and fixed before it mattered. Discovered during diligence instead, it would have stalled or killed the deal.
Six weeks is not enough time. Buyer identification, diligence and documentation take months, and a compressed timeline reduces the price even where a buyer exists.
Timing
| Start | Prospects |
|---|---|
| 12+ months before a fee deadline | Full process possible |
| 6 months | Workable, compressed |
| 3 months | Difficult |
| 6 weeks | Very unlikely |
| After the grace period closes | Worth nothing |
Run a portfolio review annually against eighteen months of deadlines, so selling remains an option rather than a missed one. See patent portfolio management.
What the engagement should say
| Term | Why |
|---|---|
| Commission percentage and base | Gross or net of what |
| Exclusivity period, with an end date | Not open-ended |
| Carve-outs for introduced buyers | Negotiable |
| Tail period after termination | How long commission survives |
| What is billed separately | Avoid surprises |
| Confidentiality | Before any disclosure |
| Whether foreign members are included | Scope |
The tail period catches people. A commission surviving twelve months after termination is normal; one surviving indefinitely is not.
When to sell directly
| Situation | Direct sale viable |
|---|---|
| You already know the buyer | Yes |
| A competitor has approached you | Yes |
| A licensee wants ownership | Yes |
| No idea who would want it | Broker adds most here |
| Complex family across jurisdictions | Broker |
Buyer access is what you are paying for. Where you already have it, the commission buys process rather than reach.
Patent brokers without upfront fees: the checklist
- Understand contingency means selection. Most patents offered are declined.
- Treat a decline as free diagnostic information.
- Ask what the commission covers and what is billed separately.
- Bound the exclusivity period. Never open-ended.
- Negotiate carve-outs for buyers you introduce.
- Demand the §297 disclosure from anyone charging you upfront.
- Verify in-force status and the recorded chain yourself first. Both free.
- Calculate remaining term from the earliest parent in the family.
- Build a claim chart before approaching anyone. It is the value driver.
- Start twelve months before a fee deadline, not six weeks.